San Diego, Calif., and Nanjing, JiangSu – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY® System for companion diagnostics and pharmacogenetic testing in China. As a leading pharmaceutical company with strong connections to China’s […]
Location: Cambridge First-to-market Edit-R CRISPRa arrayed crRNA libraries enable native gene overexpression for high-throughput gain-of-function screening Available as small gene families, bespoke collections, the druggable genome, or human genome-wide collection Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in the application of gene editing and gene modulation to deliver inspired cell […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware denied a motion to dismiss filed on December 14, 2017 by Oxford Nanopore Technologies, Inc., a wholly-owned subsidiary of Oxford Nanopore Technologies Ltd. ONT had sought to dismiss Pacific Biosciences’ complaint for […]
New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way for Future Growth Resulting Cost Savings to be Reinvested Back into the Business CINCINNATI — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the realignment of its business structure aimed at […]
New and updated assays increase application areas and improve performance MINNEAPOLIS — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use. The continued investment in […]
Location: Cambridge Horizon’s Glutamine Synthetase-Knockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further validates the use of Horizon’s Bioproduction cell line platform for the manufacture of biotherapeutics Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader […]
Samples to be collected from over 25,000 participants in Nurses’ Health Study II (NHSII) cohort BETHLEHEM, PA. – DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services, today announced that the Harvard T.H. Chan School of Public Health has selected DNA Genotek’s OMNIgene® family of microbiome collection devices to provide reliable […]
FARMINGDALE, N.Y. – EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, announced its technological and financial support for new skincare startup EpigenCare. William Lee, who served as an operations executive for a number of years at EpiGentek, spearheads EpigenCare’s venture as its CEO. EpiGentek will work in collaboration with EpigenCare to […]
Boston – The Pistoia Alliance, a global alliance of life science companies, vendors, publishers and academic groups, and Scilligence Corporation are pleased to announce the release of the major new extension to the HELM Web Editor. New functionalities enable the editor to support the representation of biomolecules with some structural uncertainty or ambiguity and also adds […]
SAN FRANCISCO — Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National Cancer Institute, along with agreements with research groups at three other academic and pharma institutions, to demonstrate the clinical utility of their immune-profiling assay, Cofactor Paragon. These research collaborations are centered […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
